Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Calcifediol · Calderol, Rayaldee

Small molecule · Modulator of vitamin D receptor (VDR) · developed by Organon Usa

Approved FDA, Aug 1980
4 Registered trials

What is Calcifediol?

Calcifediol is a prohormone of calcitriol, the active form of vitamin D3. It is converted mainly in the kidney by CYP27B1 to calcitriol, which binds the vitamin D receptor to increase intestinal calcium and phosphorus absorption and reduce parathyroid hormone synthesis. It is studied in chronic kidney disease, secondary hyperparathyroidism, vitamin D deficiency and COVID-19.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Calderol, Rayaldee, CTAP101
Drug type
Small molecule
Targets
vitamin D receptor (VDR) (binding partner it blocks)
Mechanism
Modulator of vitamin D receptor (VDR)
Pathways
vitamin D signaling, calcium and phosphorus absorption, parathyroid hormone synthesis suppression
Therapy area
Endocrine, Renal & urology
Developer
Organon Usa Inc
In trials of
OPK
FDA status
Approved as Calderol, Rayaldee (August 5, 1980), NDA018312 · FDA label
UNII
P6YZ13C99Q

✅ FDA-approved uses

From the indications section of the FDA label (version of Jan 19, 2024). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03588884 Phase 4 Secondary Hyperparathyroidism Due to Renal Causes Completed OPK
NCT05543928 Phase 3 Chronic Kidney Disease stage3 Terminated OPK
NCT02282813 Phase 3 Chronic Kidney Disease Completed OPK
NCT04551911 Phase 2 COVID-19 Completed OPK

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Chronic Kidney DiseaseChronic Kidney Disease stage3Chronic Kidney Disease stage4CKD Stage 3CKD Stage 4CoronavirusCOVID-19Hyperparathyroidism, SecondarySARS-CoV2 InfectionSecondary HyperparathyroidismSecondary Hyperparathyroidism Due to Renal CausesVitamin D DeficiencyVitamin D Insufficiency

Sources

Updated Oct 25, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.